Aperio Group’s GSK GSK Stock Holding History

Aperio Group’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q4	$27M	Sell	586,352 -124,781	-18%	-$5.74M	0.08%	244
2020 Q3	$33.5M	Sell	711,133 -73,138	-9%	-$3.44M	0.11%	174
2020 Q2	$40M	Sell	784,271 -12,383	-2%	-$631K	0.15%	134
2020 Q1	$37.7M	Sell	796,654 -90,936	-10%	-$4.31M	0.17%	119
2019 Q4	$52.1M	Buy	887,590 +45,913	+5%	+$2.7M	0.19%	107
2019 Q3	$44.9M	Buy	841,677 +71,636	+9%	+$3.82M	0.18%	118
2019 Q2	$38.5M	Buy	770,041 +55,996	+8%	+$2.8M	0.16%	135
2019 Q1	$37.3M	Buy	714,045 +114,544	+19%	+$5.98M	0.16%	136
2018 Q4	$28.6M	Sell	599,501 -36,348	-6%	-$1.74M	0.14%	152
2018 Q3	$31.9M	Buy	635,849 +1,281	+0.2%	+$64.3K	0.14%	159
2018 Q2	$32M	Buy	634,568 +110,597	+21%	+$5.57M	0.15%	152
2018 Q1	$25.6M	Buy	523,971 +195,176	+59%	+$9.53M	0.13%	189
2017 Q4	$14.6M	Sell	328,795 -58,390	-15%	-$2.59M	0.07%	311
2017 Q3	$19.7M	Sell	387,185 -10,941	-3%	-$555K	0.11%	218
2017 Q2	$21.5M	Buy	398,126 +55,316	+16%	+$2.98M	0.13%	186
2017 Q1	$18.1M	Buy	342,810 +55,431	+19%	+$2.92M	0.12%	195
2016 Q4	$13.8M	Sell	287,379 -190,703	-40%	-$9.18M	0.11%	222
2016 Q3	$25.8M	Buy	478,082 +37,914	+9%	+$2.04M	0.19%	118
2016 Q2	$23.8M	Sell	440,168 -18,892	-4%	-$1.02M	0.19%	124
2016 Q1	$23.3M	Buy	459,060 +18,393	+4%	+$932K	0.2%	120
2015 Q4	$22.2M	Sell	440,667 -2,990	-0.7%	-$151K	0.2%	114
2015 Q3	$21.3M	Buy	443,657 +118,071	+36%	+$5.67M	0.22%	111
2015 Q2	$17M	Sell	325,586 -56,407	-15%	-$2.94M	0.18%	141
2015 Q1	$22M	Buy	381,993 +72,903	+24%	+$4.21M	0.25%	91
2014 Q4	$16.5M	Buy	309,090 +44,092	+17%	+$2.36M	0.2%	116
2014 Q3	$15.2M	Sell	264,998 -72,993	-22%	-$4.19M	0.21%	115
2014 Q2	$22.6M	Buy	337,991 +13,973	+4%	+$934K	0.33%	59
2014 Q1	$21.6M	Buy	+324,018	New	+$21.6M	0.3%	57
2013 Q4	–	Sell	-268,295	Closed	-$16.8M	–	57
2013 Q3	$16.8M	Buy	268,295 +42,294	+19%	+$2.65M	0.32%	52
2013 Q2	$14.1M	Buy	+226,001	New	+$14.1M	0.34%	48